Sector Chart Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.39 USD | -1.04% | -16.45% | -9.63% |
Jan. 15 | Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM | |
Jan. 15 | Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance | MT |
End-of-day quotes
Sector Diagnostic & Testing Substances
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.13B | - | |||||
13.43B | ||||||
6.56B | ||||||
6.36B | - | - | ||||
5.59B | ||||||
4.53B | - |